KHP Capital’s Merck MRK Stock Holding History

KHP Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$31K	Hold	460	–	–	0.02%	127
2018 Q2	$27K	Hold	460	–	–	0.02%	128
2018 Q1	$24K	Buy	+460	New	+$24.8K	0.02%	126

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

KHP Capital's MRK Position: Q3 2018 in Review

KHP Capital held its Merck (MRK) position steady in Q3 2018 at 460 shares worth $31K. The position accounts for 0.02% of the portfolio, ranked #127.

KHP Capital first reported a position in MRK in Q1 2018 and has held it in 3 quarters since. 2,056 funds tracked by Wall St. Rank hold MRK as of Q3 2018.

KHP Capital held 460 shares of Merck worth $31K as of Q3 2018.
KHP Capital left its Merck share count unchanged in Q3 2018.
Merck made up 0.02% of KHP Capital's portfolio in Q3 2018, its #127 holding.
KHP Capital first reported a position in Merck in Q1 2018 and has held it in 3 quarters since.
2,056 funds tracked by Wall St. Rank held Merck as of Q3 2018.

Based on KHP Capital's 13F filing for Q3 2018, filed 8 Nov 2018.